AOD-9604

Research

AOD-9604 (HGH Fragment 176-191)

Aliases
HGH Fragment 176-191, Anti-Obesity Drug 9604
Administration
Subcutaneous injection

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Benefit categories

Weight Loss & Metabolism

AOD-9604's defining research application — engineered to isolate growth hormone's fat-burning effect specifically.

Fat oxidation

Designed to trigger fat breakdown via the same beta-3 adrenergic pathway growth hormone uses, without raising IGF-1.

Lipolysis

Intended to inhibit new fat formation while promoting the breakdown of existing stored fat.